Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRECCAR 8: Surgery vs. Chemotherapy for Metastatic Rectal Cancer
NCT02314182Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Nov 2014
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rectal adenocarcinoma, sponsored by Hospices Civils de Lyon. Primary endpoint: Overall Survival at 2 years. Started Nov 2014; status: completed.
02
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT02314182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314182.